Tumor growth going FAR with KRAS FARnesylation-induced phase separation
Cell Reports · 2026-10 · 45 (10) · 117924
DOI: 10.1016/j.celrep.2026.117924 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell Reports, 2026-10. Verfasst von Sidhant Kalia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), ras Proteins, Protein Prenylation. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France.
- Institut Curie, CNRS UMR3348, INSERM U1368, University Paris Saclay, Orsay, France. Electronic address: stephan.vagner@curie.fr.
Zitieren
APA
Kalia, S., & Vagner, S. (2026). Tumor growth going FAR with KRAS FARnesylation-induced phase separation. Cell Reports, 45(10), 117924. https://doi.org/10.1016/j.celrep.2026.117924
Vancouver
Kalia S, Vagner S. Tumor growth going FAR with KRAS FARnesylation-induced phase separation. Cell Reports. 2026;45(10):117924. doi:10.1016/j.celrep.2026.117924
BibTeX
@article{Kalia2026,
author = {Kalia, Sidhant and Vagner, Stéphan},
title = {Tumor growth going FAR with KRAS FARnesylation-induced phase separation},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {10},
pages = {117924},
doi = {10.1016/j.celrep.2026.117924}
}
EUVIMED